Target intelligence / Profile preview

TTC23L antisense RNA 1 (TTC23L-AS1)

Target
TTC23L-AS1
Molecular classification
Long non-coding RNA, Antisense RNA
01

Overview

TTC23L antisense RNA 1 (TTC23L-AS1) is a gene encoding a long non-coding antisense RNA that is transcribed in the opposite direction to the TTC23L gene on chromosome 17 in humans. Antisense lncRNAs like TTC23L-AS1 are known to regulate gene expression through mechanisms such as chromatin remodeling, hybridization to target mRNAs, and modulation of transcription at their loci of origin or at distant sites. Antisense RNAs can modulate key cellular processes, including epigenetic silencing and gene activation, and are being explored for their potential relevance to diseases such as cancer. However, there is no current evidence implicating TTC23L-AS1 as a therapeutic target or druggable molecule. TTC23L-AS1 is classified as a long non-coding RNA based on its annotation in major gene databases, such as Ensembl, and has not been identified as encoding a protein or functioning as a traditional therapeutic receptor or enzyme. The biological function of TTC23L-AS1, like many antisense RNAs, is likely related to the regulation of gene expression, but specific roles and disease associations remain to be clarified.

Other names
CTD-2517O10.6TTC23L-AS1
02

Biological functions

Regulation of gene expressionEpigenetic regulationPotential involvement in chromatin modification
03

Disease associations

Evidence suggests certain antisense RNAs can promote or suppress cancer and other diseases, but no direct disease role specifically established for TTC23L-AS1 as of current knowledge

Beyond the preview

Go deeper on TTC23L antisense RNA 1 (TTC23L-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TTC23L antisense RNA 1 (TTC23L-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call